Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Nephrology

Does Caffeine Affect Cyst Growth and cAMP in ADPKD?

At a Glance

For most adults with ADPKD, moderate caffeine—about one to two standard cups of coffee daily—has not been shown to meaningfully speed kidney-function decline or kidney failure, although very high doses are unstudied and caffeine may temporarily raise blood pressure.

You do not need to completely give up coffee or caffeine if you have Autosomal Dominant Polycystic Kidney Disease (ADPKD). While early laboratory and animal studies suggested that caffeine might accelerate kidney enlargement, long-term observational studies in humans have reassuringly shown that moderate caffeine intake does not appear to hasten the decline of kidney function or the progression to kidney failure [1][2].

However, it is important to understand that these studies observed dietary habits over time rather than proving zero risk, and they did not test the safety of extremely high or concentrated caffeine doses. Here is what the current medical evidence says about caffeine, how it interacts with the biology of ADPKD, and what it means for your daily diet.

The Biological Theory: Caffeine and cAMP

To understand why caffeine is frequently debated in the ADPKD community, it helps to look at the mechanisms driving the disease.

In ADPKD, genetic mutations affect proteins called polycystins. When these proteins do not function correctly, it disrupts normal cell signaling and leads to increased levels of a messenger molecule inside your cells called cAMP (cyclic adenosine monophosphate) [3][4].

cAMP is an important signaling pathway for cyst growth because it does two things:

  1. It signals the cells lining the cysts to multiply (proliferation) [5].
  2. It activates a chloride channel called CFTR, which helps drive the movement of salt and water into the cysts, causing them to expand (fluid secretion) [3][4].

Your body naturally controls cAMP levels using enzymes called phosphodiesterases (PDEs), which break down cAMP [6]. At very high concentrations in a laboratory setting, caffeine is a weak PDE inhibitor, meaning it can stop these enzymes from doing their job. In theory, consuming caffeine should prevent the breakdown of cAMP, leading to higher cAMP levels and faster cyst growth [6].

In some animal studies involving mice with ADPKD, administering very high doses of caffeine worsened kidney enlargement and decreased kidney function [7]. However, these studies did not actually detect an increase in renal (kidney) cAMP levels in the mice, suggesting this high-concentration laboratory theory does not perfectly translate to how routine caffeine intake behaves in a living body [7].

What the Human Evidence Shows

Because mice and cell cultures do not perfectly mimic human biology, researchers have tracked caffeine consumption in large groups of ADPKD patients to see what happens in real life. These studies measure disease progression using two main markers: eGFR (a blood test estimating how well the kidneys filter waste) and Total Kidney Volume or TKV (an imaging measurement of kidney size). They do not directly measure individual cyst growth or cAMP levels in the kidneys.

The most prominent study, the CRISP cohort, followed over 200 adults with ADPKD for a median of 12.5 years [1]. The researchers found:

  • Any caffeine consumption was associated with a very small increase in the rate of kidney enlargement (modeled at about 0.6% faster per year) [1].
  • However, caffeine consumption did not result in a faster decline in actual kidney filtering function (measured GFR), nor did it speed up the time to end-stage kidney disease (kidney failure) or death [1].

A separate Swiss study following ADPKD patients for over four years similarly found no statistically significant differences in total kidney volume or eGFR decline between coffee drinkers and non-drinkers [2].

Ultimately, these observational human studies concluded that moderate caffeine does not have a clinically important detrimental effect on overall ADPKD progression [1][2].

Should “Rapid Progressors” Avoid Caffeine?

If you have been told you are at high risk for rapid progression (often determined by assessing your TKV, age, and genetics), you might wonder if you need to be extra strict.

Currently, there are no medical guidelines requiring adults with ADPKD—even rapid progressors—to completely eliminate moderate coffee or caffeine intake [8]. Total caffeine avoidance has not been proven to act as a disease-modifying treatment [1][2].

Instead, managing rapid progression focuses on formal risk assessment, individualized blood pressure control, and, when appropriate, targeted medications [8]. For example, tolvaptan is a vasopressin V2-receptor antagonist that specifically reduces vasopressin-mediated cAMP signaling [8]. It is prescribed only for selected patients at high risk of rapid progression and requires close monitoring by a nephrologist [8].

Practical Dietary Guidelines for Caffeine

While moderate caffeine intake has not been shown to accelerate ADPKD progression, you should still be mindful of your total intake and overall health:

  • Define “moderate” intake: Moderate generally means about 1 to 2 standard (8-ounce) cups of brewed coffee per day. This is very different from consuming large café drinks or multiple strong teas, which can contain far more caffeine [1][2]. The safety of extremely high or concentrated caffeine doses has not been established.
  • Watch for “hidden” caffeine: Coffee and tea are not the only sources. Be careful with energy drinks, pre-workout powders, high-caffeine sodas, and certain over-the-counter medications [9]. Specifically, check headache pills, as some combine caffeine with NSAIDs (like ibuprofen), which can be harmful to your kidneys [10].
  • Monitor your blood pressure: Caffeine can temporarily raise blood pressure in some people [11]. Because high blood pressure damages ADPKD kidneys, ensure your caffeine habit isn’t causing spikes [12][13]. If recommended by your care team, measure your blood pressure at rest with a validated home cuff to see if it changes after drinking caffeine.
  • Check your medications: Some drugs (such as certain antidepressants or antibiotics) can slow down how your liver processes caffeine, increasing the amount in your blood [14][15]. Always ask your pharmacist or doctor if any of your medications interact with caffeine.

Common questions in this guide

Can I drink coffee if I have ADPKD?
For most adults with ADPKD, moderate caffeine intake has not been shown to meaningfully worsen kidney function or increase the risk of kidney failure. Human studies are observational, so they cannot prove that every amount is risk-free; discuss your intake with your care team.
Does caffeine raise cAMP and make ADPKD cysts grow faster?
At very high concentrations in laboratory settings, caffeine can weakly slow the breakdown of cAMP, which could theoretically promote cyst-cell growth and fluid secretion. However, human studies of usual caffeine intake have not shown a clinically important effect on overall ADPKD progression, and they did not directly measure kidney cAMP or individual cyst growth.
Should people with rapidly progressing ADPKD avoid all caffeine?
No current medical guideline requires adults with ADPKD, including those at high risk of rapid progression, to eliminate moderate caffeine. Risk assessment, blood pressure control, and treatments such as tolvaptan when appropriate are the established focus; your nephrologist can personalize advice.
How much caffeine is considered moderate with ADPKD?
The page describes moderate intake as about one to two standard 8-ounce cups of brewed coffee daily, but caffeine content varies widely by drink size and preparation. The safety of extremely high or concentrated caffeine doses has not been established, so include energy drinks, tea, soda, supplements, and medications when estimating your total.
Can caffeine affect blood pressure in someone with ADPKD?
Caffeine can temporarily raise blood pressure in some people, and uncontrolled high blood pressure can further strain ADPKD kidneys. If your clinician recommends it, check resting blood pressure with a validated home cuff before and after caffeine and share the record with your care team.
Could energy drinks or medications make caffeine riskier for ADPKD?
Yes. Energy drinks, pre-workout products, sodas, and some over-the-counter medicines can substantially increase total caffeine, while headache medicines may also contain kidney-harming NSAIDs such as ibuprofen. Some prescription medicines can slow caffeine breakdown, so ask a pharmacist or doctor to review your medications.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current blood pressure and kidney function, what daily caffeine amount (in milligrams) fits my health goals?
  2. 2.Should I monitor my blood pressure at home with a cuff to see if caffeine causes spikes, and how should I record this?
  3. 3.Are any of my current medications interacting with how my body processes caffeine?
  4. 4.Do I have any other health conditions, like heart rhythm issues, that mean I should restrict my caffeine intake more than a typical ADPKD patient?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort.

    McKenzie KA, El Ters M, Torres VE, et al.

    BMC nephrology 2018; (19(1)):378 doi:10.1186/s12882-018-1182-0.

    PMID: 30591038
  2. 2

    Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study.

    Girardat-Rotar L, Puhan MA, Braun J, Serra AL

    Journal of nephrology 2018; (31(1)):87-94 doi:10.1007/s40620-017-0396-8.

    PMID: 28386880
  3. 3

    Pathogenic Pathways and Therapeutic Strategies in Autosomal Dominant Polycystic Kidney Disease (ADPKD).

    Preval KM, Smith AO, Pazour GJ

    Journal of cellular signaling 2025; (6(4)):156-169 doi:10.33696/signaling.6.144.

    PMID: 41608384
  4. 4

    Targeting chloride transport in autosomal dominant polycystic kidney disease.

    Jouret F, Devuyst O

    Cellular signalling 2020; (73()):109703 doi:10.1016/j.cellsig.2020.109703.

    PMID: 32619563
  5. 5

    EGR1 Nuclear Condensates Promote Renal Cyst Development in Polycystic Kidney Disease.

    Ren C, Wu Z, Li M, et al.

    Exploration (Beijing, China) 2026; (6(1)):20240285 doi:10.1002/EXP.20240285.

    PMID: 41810077
  6. 6

    Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.

    Pinto CS, Raman A, Reif GA, et al.

    Journal of the American Society of Nephrology : JASN 2016; (27(4)):1124-34 doi:10.1681/ASN.2015010047.

    PMID: 26289612
  7. 7

    Caffeine Accelerates Cystic Kidney Disease in a Pkd1-Deficient Mouse Model.

    Meca R, Balbo BE, Ormanji MS, et al.

    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2019; (52(5)):1061-1074 doi:10.33594/000000072.

    PMID: 30977988
  8. 8

    Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice.

    Gansevoort RT, Arici M, Benzing T, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016; (31(3)):337-48 doi:10.1093/ndt/gfv456.

    PMID: 26908832
  9. 9

    Bioassay for Determining the Concentrations of Caffeine and Individual Methylxanthines in Complex Samples.

    Gutierrez AE, Shah P, Rex AE, et al.

    Applied and environmental microbiology 2019; (85(23)) doi:10.1128/AEM.01965-19.

    PMID: 31540989
  10. 10

    Review of Caffeine-Related Fatalities along with Postmortem Blood Concentrations in 51 Poisoning Deaths.

    Jones AW

    Journal of analytical toxicology 2017; (41(3)):167-172 doi:10.1093/jat/bkx011.

    PMID: 28334840
  11. 11

    CYP1A2 Genetic Variation, Coffee Intake, and Kidney Dysfunction.

    Mahdavi S, Palatini P, El-Sohemy A

    JAMA network open 2023; (6(1)):e2247868 doi:10.1001/jamanetworkopen.2022.47868.

    PMID: 36701157
  12. 12

    Associations of Urinary Caffeine and Caffeine Metabolites With Arterial Stiffness in a Large Population-Based Study.

    Ponte B, Pruijm M, Ackermann D, et al.

    Mayo Clinic proceedings 2018; (93(5)):586-596 doi:10.1016/j.mayocp.2017.12.010.

    PMID: 29551227
  13. 13

    RETRACTED: Determinants of Disease Progression in Autosomal Dominant Polycystic Kidney Disease.

    Kebede MA, Mengistu YT, Loge BY, et al.

    Journal of personalized medicine 2024; (14(9)) doi:10.3390/jpm14090936.

    PMID: 39338190
  14. 14

    An autopsy case of BRONTM overdose with multiple drug ingestion.

    Takei S, Kinoshita H, Jamal M, et al.

    Legal medicine (Tokyo, Japan) 2023; (64()):102294 doi:10.1016/j.legalmed.2023.102294.

    PMID: 37369168
  15. 15

    Is there a sex difference in adult salivary clearance of caffeine (1,3,7-trimethylpurine-2,6-dione)?

    Puri BK, Heard CR, Monro JA

    Journal of oral biology and craniofacial research 2020; (10(2)):20-22 doi:10.1016/j.jobcr.2020.01.010.

    PMID: 32071850

This page is for informational purposes only and does not constitute medical advice. It explains general evidence about caffeine and ADPKD; ask your nephrologist or care team about caffeine, blood pressure, and medication safety for your situation.

Get notified when new evidence is published on Autosomal dominant polycystic kidney disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.